Clearmind Medicine Inc. announced a private placement of 1,468,000 common shares at a price of $1.60 per share for gross proceeds of $2,348,800; and 32,000 pre-funded warrants at a price of $1.60 per warrant for gross proceeds of $51,200; for aggregate gross proceeds of $2,400,000 on January 16, 2024. The company also issued 1,500,000 unregistered common warrants to purchase 1,500,000 common shares. The pre-funded warrants are immediately exercisable at an exercise price of $ 0.0001 per common share and will not expire until exercised in full.

The unregistered common warrants have an exercise price of $ 1.60 per common share, are immediately exercisable, and expire five years from the date of issuance. The company incurred estimated offering expenses of $575,227.